- Practice and Procedures Order
- Case Management and Scheduling Order No. 1
- Order Appointing Counsel to Leadership Positions
- Case Management and Scheduling Order No. 2
- Show Cause Order
- Case Management Scheduling Order No.3
- Order Re: Appointment of Plaintiffs' Liaison Counsel
- Sanctions Order
- Show Cause Order 2
- Order Outlining Terms of Common Benefit Fund
- Show Cause Order 3
- Show Cause Order 4
- Memorandum, Opinion & Order re: Xanodyne Pharmaceuticals, Inc.'s Motions to Dismiss
- Memorandum, Opinion & Order re: Generic Defendents Motion to Dismiss
- Memorandum, Opinion & Order re: Eli Lilly Motion to Dismiss and Judgment on Pleadings
- Case Management and Scheduling Order No. 4
- Order Directing Plaintiffs to Show Cause why claims as to Generic Defendants should not be Dismissed
- Memorandum Opinion and Order granting Defendant Endo Pharmaceuticals Holdings, Inc.'s and Defendant Endo Pharmaceuticals, Inc.'s Motion to Dismiss
- Order Directing Plaintiffs to Show Cause Why Claims as to Generic Defendants Should not be Dismissed
- Agreed Order Re Eli Lilly and Company's Dispositive Motions in Cases in which Plaintiffs have not Amended Their Pleadings
- Procedures Governing Discovery
- Document Production Protocol and Cost of Production Order
- Amended Leadership Order
Text Size:
